Colorectal Cancer Screening: Scientific Review

Published on Mar 12, 2003in JAMA45.54
· DOI :10.1001/JAMA.289.10.1288
Judith M. E. Walsh28
Estimated H-index: 28
(UCSF: University of California, San Francisco),
Jonathan P. Terdiman40
Estimated H-index: 40
ContextScreening for colorectal cancer clearly reduces colorectal cancer mortality, yet many eligible adults remain unscreened. Several screening tests are available, and various professional organizations have differing recommendations on which screening test to use. Clinicians are challenged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in choosing what tests to receive.ObjectiveTo critically assess the evidence for use of the available colorectal cancer screening tests, including fecal occult blood tests, sigmoidoscopy, colonoscopy, double-contrast barium enema, and newer tests, such as virtual colonoscopy and stool-based molecular screening.Data SourcesAll relevant English-language articles were identified using PubMed (January 1966-August 2002), published meta-analyses, reference lists of key articles, and expert consultation.Data ExtractionStudies that evaluated colorectal cancer screening in healthy individuals and assessed clinical outcomes were included. Evidence from randomized controlled trials was considered to be of highest quality, followed by observational evidence. Diagnostic accuracy studies were evaluated when randomized controlled trials and observational studies were not available or did not provide adequate evidence. Studies were excluded if they did not evaluate colorectal screening tests and if they did not evaluate average-risk individuals.Data SynthesisRandomized controlled trials have shown that fecal occult blood testing can reduce colorectal cancer incidence and mortality. Case-control studies have shown that sigmoidoscopy is associated with a reduction in mortality, and observational studies suggest colonoscopy is effective as well. Combining fecal occult blood testing and sigmoidoscopy may decrease mortality and can increase diagnostic yield.ConclusionThe recommendation that all men and women aged 50 years or older undergo screening for colorectal cancer is supported by a large body of direct and indirect evidence. At present, the available evidence does not currently support choosing one test over another.
📖 Papers frequently viewed together
13 Authors (Steven H. Woolf)
1,959 Citations
2,477 Citations
2,810 Citations
#1Graeme P. Young (Flinders University)H-Index: 81
#2D. James B. St. John (Royal Melbourne Hospital)H-Index: 23
Last. Paul RozenH-Index: 45
view all 4 authors...
OBJECTIVE: There is now strong evidence that screening for colorectal cancer with fecal occult blood tests (FOBTs) is effective in reducing the incidence and mortality of this disease. Various FOBTs are now available with a wide range of evidence supporting their use. The purpose of this study was to review published data on the performance of these FOBTs to provide recommendations for their effective use in screening. METHODS: A joint committee representing the World Health Organization and the...
141 CitationsSource
#1John H. Scholefield (University of Nottingham)H-Index: 61
#2Sue MossH-Index: 68
Last. Jack D. HardcastleH-Index: 56
view all 5 authors...
Background: Three large randomised trials have shown that screening for colorectal cancer using faecal occult blood (FOB) tests can reduce the mortality from this disease. Two national pilot studies have recently been launched in the UK to investigate the feasibility of population screening for colorectal cancer in the National Health Service. The largest of the randomised trials was conducted in Nottingham and randomised 152 850 individuals between the ages of 45 and 74 years to receive biennia...
234 CitationsSource
#1B. Avidan (VA: United States Department of Veterans Affairs)H-Index: 12
#2Amnon SonnenbergH-Index: 62
Last. Stephen J. SontagH-Index: 36
view all 6 authors...
Abstract OBJECTIVE: The fear that colorectal adenomas were missed on initial colonoscopy or that new adenomas have developed is often a rationale for repeating a colonoscopic examination. The aim of this study was to delineate risk factors associated with recurrence of colorectal adenomas after an initial baseline screening colonoscopy. METHODS: The study population comprised 875 subjects who underwent a baseline screening colonoscopy followed by a second examination 1–5 yr later. Multiple logis...
80 CitationsSource
Summary Background This randomised controlled trial is examining the hypothesis that a single flexible sigmoidoscopy screening offered at around age 60 years can lower the incidence and mortality of colorectal cancer. We report here on acceptability, safety, feasibility, and yield. Methods Men and women aged 55–64 years, in 14 UK centres, who responded to a mailed questionnaire that they would attend for flexible sigmoidoscopy screening if invited, were randomly assigned screening or control (ra...
429 CitationsSource
Background: Indirect evidence and modeling analyses suggest that colonoscopy may be the most cost-effective way to screen the average-risk population for colorectal neoplasia. However, the success and safety of primary colonoscopic screening has not been prospectively evaluated in a multicenter trial. Methods: Asymptomatic subjects age 50 to 75 years who had not undergone examination of the colon within 10 years were recruited from the general medicine clinics of 13 Department of Veterans Affair...
374 CitationsSource
#1Giovanni Traverso (Johns Hopkins University)H-Index: 30
#2Anthony P. ShuberH-Index: 25
Last. Bert Vogelstein (HHMI: Howard Hughes Medical Institute)H-Index: 258
view all 9 authors...
Summary Detection of mutations in faecal DNA represents a promising, non-invasive approach for detecting colorectal cancers in average-risk populations. One of the first practical applications of this technology involves the examination of microsatellite markers in sporadic cancers with mismatch-repair deficiencies. Since such cancers nearly always occur in the proximal colon, this test might be useful as an adjunct to sigmoidoscopy, which detects only distal colorectal lesions. We report here t...
148 CitationsSource
#1Giovanni Traverso (Johns Hopkins University)H-Index: 30
#2Anthony P. ShuberH-Index: 25
Last. Bert Vogelstein (Johns Hopkins University)H-Index: 258
view all 10 authors...
Background Noninvasive methods for detecting colorectal tumors have the potential to reduce morbidity and mortality from this disease. The mutations in the adenomatous polyposis coli (APC) gene that initiate colorectal tumors theoretically provide an optimal marker for detecting colorectal tumors. The purpose of our study was to determine the feasibility of detecting APC mutations in fecal DNA with the use of newly developed methods. Methods We purified DNA from routinely collected stool samples...
326 CitationsSource
#1Ole Dan Jørgensen (OUH: Odense University Hospital)H-Index: 22
#2Ole KronborgH-Index: 6
Last. Claus FengerH-Index: 41
view all 3 authors...
Background: Three randomised trials have demonstrated reduction in mortality from colorectal cancer (CRC) by repeated screening with faecal occult blood tests, including the trial presented here, which is the only one still in progress. Aims: To evaluate reduction in mortality after seven screening rounds and the possible influence of compliance on mortality from CRC. Methods: At Funen in Denmark, random allocation to biennial screening with Hemoccult-II in 30 967 subjects aged 45–75 years and 3...
330 CitationsSource
#1Geetanjali A. Akerkar (SFVAMC: San Francisco VA Medical Center)H-Index: 7
#3Raymond K. Hung (SFVAMC: San Francisco VA Medical Center)H-Index: 3
Last. Kenneth R. McQuaid (SFVAMC: San Francisco VA Medical Center)H-Index: 40
view all 4 authors...
Abstract Background: Virtual colonoscopy has excellent sensitivity for the detection of cancer and polyps greater than 1 cm in diameter. For virtual colonoscopy to succeed as a screening test for colorectal neoplasia, it must be well tolerated and accepted by patients. Patients' experiences with virtual colonoscopy and conventional colonoscopy were assessed and compared. Methods: Patients referred to the GI clinic for colonoscopy for any indication were recruited to undergo virtual colonoscopy b...
122 CitationsSource
Background Fecal occult-blood testing and sigmoidoscopy have been recommended for screening for colorectal cancer, but the sensitivity of such combined testing for detecting neoplasia is uncertain. At 13 Veterans Affairs medical centers, we performed colonoscopy to determine the prevalence of neoplasia and the sensitivity of one-time screening with a fecal occult-blood test plus sigmoidoscopy. Methods Asymptomatic subjects (age range, 50 to 75 years) provided stool specimens on cards from three ...
527 CitationsSource
Cited By379
#1Yutong WangH-Index: 2
#2Hui NieH-Index: 2
Last. Chunlin OuH-Index: 12
view all 7 authors...
#1Qun Zhao (HUM: Hubei University of Medicine)H-Index: 4
#2Xinran ChengH-Index: 1
Last. Xianjun Yu (HUM: Hubei University of Medicine)H-Index: 4
view all 14 authors...
Mixed lineage kinase domain-like protein (MLKL) plays an important role in necroptosis, but the role and mechanism of MLKL in intestinal tumorigenesis remain unclear. Here, we found that hematopoietic- and nonhematopoietic-derived MLKL affected intestinal inflammation, but nonhematopoietic-derived MLKL primarily inhibited intestinal tumorigenesis. Loss of MLKL enhanced intestinal regeneration and the susceptibility to intestinal tumorigenesis in Apcmin/+ mice by hyperactivating the Janus kinase ...
3 CitationsSource
#1Pingfu HouH-Index: 15
#2Sen MengH-Index: 2
Last. Jin BaiH-Index: 20
view all 9 authors...
Increasing studies have shown that long noncoding RNAs (lncRNAs) are pivotal regulators participating in carcinogenic progression and tumor metastasis in colorectal cancer (CRC). Although lncRNA long intergenic noncoding RNA 460 (LINC00460) has been reported in CRC, the role and molecular mechanism of LINC00460 in CRC progression still requires exploration. The expression levels of LINC00460 were analyzed by using a tissue microarray containing 498 CRC tissues and their corresponding non-tumor a...
11 CitationsSource
#1Hariti Saluja (Flinders University)H-Index: 2
#2Graeme P. Young (Flinders University)H-Index: 81
Last. Erin L. Symonds (Flinders Medical Centre)H-Index: 20
view all 4 authors...
BACKGROUND DNA methylated in BCAT1 and IKZF1 are promising circulating tumor DNA (ctDNA) biomarkers for colorectal cancer (CRC) detection. This study tested for variables that might be associated with their detection in patients without colonoscopically-evident CRC- so-called "false positives". METHODS A retrospective review of demographic and clinical variables was conducted on patients who were assayed for these biomarkers prior to a colonoscopy for any indication. Potential relationships betw...
1 CitationsSource
#1Xiaoyun He (CSU: Central South University)H-Index: 2
#2Bingbing YuH-Index: 1
Last. Chunlin OuH-Index: 12
view all 7 authors...
Emerging evidence indicates that long noncoding RNAs (lncRNAs) are closely associated with colorectal cancer (CRC) tumorigenesis. One example is lncRNA Deleted in Lymphocytic Leukemia 2 (DLEU2). However, how DLEU2 contributes to CRC is still poorly understood. This study sought to investigate the effects of DLEU2 on CRC pathogenesis, and the underlying mechanism involved. Using a quantitative real-time polymerase chain reaction (qRT-PCR) assay, we demonstrated that the expression levels of DLEU2...
4 CitationsSource
#1Joydev Ghosh (Bharat Electronics)H-Index: 1
#2A. K. Sharma (Bharat Electronics)
Last. S. Tomar (Bharat Electronics)
view all 3 authors...
The demand for research in the medical field is growing at a very rapid rate which can be seen in the unprecedented progress of COVID19 medication and detection development which take a lot of time and effort null But due to recent advancement of Machine Learning and Artificial Intelligence (i e null ML/AI) in the medical field, it has been observed that the time frame for the development of such medications and detection has reduced a lot null This chapter paves the way for such demand by combi...
#1Cheng Wang (China Jiliang University)
#2Jun-Bin Yan (ZJNU: Zhejiang Chinese Medical University)H-Index: 1
Last. Sumei Xu (ZJNU: Zhejiang Chinese Medical University)H-Index: 1
view all 5 authors...
Background: In China, the prevalence and mortality of colorectal cancer (CRC) have always been high, and more than 95% of CRC have evolved from colorectal polyps (CPs), especially adenoma. Early detection and treatment of CPs through colonoscopy is essential to reduce the incidence of CRC. Helicobacter pylori (Hp) is regarded as a risk factor for gastritis and gastric cancer and may also be a risk factor for CPs and CRC. However, few studies based on volume clinical cases existed in China to cla...
#1Xiaofei Miao (Nanjing Medical University)H-Index: 5
#2Zhong Xi (Nanjing Medical University)H-Index: 3
Last. Tong Wang (Nanjing Medical University)H-Index: 7
view all 8 authors...
Abstract Background Circular RNAs are crucial in tumorigenesis. However, little is known about their functions in colorectal cancer (CRC). Circ-SMARCA5 was found to be an oncogene or tumor suppresser in different types of cancers, but its exact role in CRC remains unknown. Here, we aim to identify the role of circ-SMARCA5 in CRC development. Methods Circ-SMARCA5 expression was determined by qRT-PCR. CRC cell proliferation, migration, and invasion were detected by CCK-8, wound healing, and Transw...
4 CitationsSource
#1Louise C. Walter (SFVAMC: San Francisco VA Medical Center)H-Index: 51
2 CitationsSource